BRCA1- und -2-Mutationen – Zum erhöhten Brustkrebsrisiko durch die Pille bei BRCA1- und BRCA2-Mutation

J. M. Wenderlein

doi:10.1055/s-0033-1346950

Senologie - Zeitschrift für Mammadiagnostik und -therapie, Inhaltsverzeichnis

Senologie - Zeitschrift für Mammadiagnostik und -therapie 2013; 10(4): 208-211
DOI: 10.1055/s-0033-1346950

Aktuell diskutiert

Georg Thieme Verlag KG Stuttgart · New York

BRCA1- und -2-Mutationen – Zum erhöhten Brustkrebsrisiko durch die Pille bei BRCA1- und BRCA2-Mutation

J. M. Wenderlein

Abstract

Volltext

Referenzen

Literatur
1 McLaughlin JR, Risch HA, Lubinski J et al. Risk factors for ovarian cancer in carriers of BRCA1 or BRCA2 mutations. Lancet Oncol 2007; 8: 26-34
2 Marchbanks PA, McDonald JA, Wilson HG et al. Oral contraceptives and the risk of breast cancer. NEJM 2002; 346: 2025-2032
3 Haile RW, Thomas DC, McGuire V et al. BRCA1 and BRCA2 mutation carriers, oral contraceptive use, and breast cancer before age 50. Cancer Epidemiol Biomarkers Prev 2006; 15: 1863-1870
4 Iodice S, Barile M, Rotmensz N et al. Oral contraceptive use and breast or ovarian cancer risk in BRCA1/2 carriers: a meta-analysis. Eur J Cancer 2010; 46: 2275-2284
5 Rebbeck TR, Levin AM, Eisen A et al. Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers. J Natl Cancer Inst 1999; 91: 1475-1479
6 Kurian AW, Sigal BM, Plevritis SK. Survival analysis of cancer risk reduction strategies for BRCA1/2 mutation carriers. JCO 2010; 28: 222-231
7 Rookus MA, Brohet RM, Andrien N et al. Oral contraceptives and breast cancer risk in the International BRCA1/2 Carrier Cohort Study (IBCCS). Breast Cancer Research 2005; 7 (Suppl. 02) P1.10
8 Meindl A, Ditsch N, Kast K et al. Hereditary breast and ovarian cancer – new genes, new treatments, new concepts. Dtsch Arztebl Int 2011; 108: 323-330
9 Reid RL, McNaught J. Progesterone-only and non-hormonal contraception in the breast cancer survivor: Joint review and committee opinion of the Society of Obstetricians and Gynaecologists of Canada and the Society of Gynecologic Oncologists of Canada. J Obstet Gynaecol Can 2006; 28: 616-639
10 Gaffield ME, Culwell KR, Ravi A. Oral contraceptives and family history of breast cancer. Contraception 2009; 80: 372-380
11 Milne RL, Knight JA, John EM et al. Oral contraceptive use and risk of early-onset breast cancer in carriers and noncarriers of BRCA1 and BRCA2 mutations. Cancer Epidemiol Biomarkers Prev 2005; 14: 350-356
12 Collaborative Group on Hormonal Factors in Breast. Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies. Cancer. Lancet 1996; 347: 1713-1727